MPP+ inhibits proliferation of PC12 cells by a p21(WAF1/Cip1)-dependent pathway and induces cell death in cells

F Soldner1, M Weller, S Haid

  • 1Department of Neurology, University of Tübingen, Hoppe-Seyler-Str. 3, Tübingen, D-72076, Germany.

Insights

1-methyl-4-phenylpyridinium (MPP+) inhibits dopaminergic PC12 cell proliferation and causes non-apoptotic cell death by inducing p21(WAF1/Cip1) expression, preventing apoptosis until energy depletion.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Parkinson's disease (PD) pathogenesis involves dopaminergic neuron loss, but the exact cell death mechanisms remain unclear.
  • 1-methyl-4-phenylpyridinium (MPP+), the toxic metabolite of MPTP, is a widely used model toxin to study PD-related neurodegeneration.
  • MPP+ toxicity is traditionally attributed to inhibition of mitochondrial complex I.

Purpose of the Study:

  • To elucidate the molecular and biochemical mechanisms underlying MPP+-induced cell death in dopaminergic PC12 cells.
  • To investigate the role of cell cycle regulation and apoptosis in MPP+-induced neurotoxicity.
  • To differentiate between direct MPP+ effects and secondary consequences of energy depletion.

Main Methods:

  • Treatment of PC12 cells and other cell lines (SH-SY5Y, p21(-/-) MEFs) with MPP+.
  • Analysis of cell proliferation, cell death morphology, and apoptosis markers (caspase inhibitors).
  • Assessment of mitochondrial function (complex I activity) and cell cycle progression (flow cytometry, p21(WAF1/Cip1) expression).

Main Results:

  • MPP+ primarily inhibited PC12 cell proliferation and induced cell death after energy substrate depletion, without typical apoptotic features.
  • MPP+-induced growth inhibition occurred independently of mitochondrial complex I activity.
  • MPP+ caused cell cycle arrest at the G0/G1 to S phase transition, linked to increased p21(WAF1/Cip1) expression.
  • In p21-deficient cells, MPP+ induced apoptosis, suggesting p21-mediated growth arrest initially prevents cell death.

Conclusions:

  • MPP+ induces a dual effect: early growth arrest via p21(WAF1/Cip1) upregulation, followed by non-apoptotic cell death upon energy depletion.
  • The findings challenge the sole reliance on mitochondrial complex I inhibition for MPP+ toxicity and highlight the role of cell cycle regulation in neuroprotection.
  • This study provides novel insights into the complex cell death pathways relevant to Parkinson's disease.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...